RT Journal Article SR Electronic T1 EPV115/#333 Interim analysis of 10-year data regarding presentation and management of uterine carcinosarcoma (UCS) cases across the thames valley cancer alliance network JF International Journal of Gynecologic Cancer JO Int J Gynecol Cancer FD BMJ Publishing Group Ltd SP A75 OP A76 DO 10.1136/ijgc-2021-IGCS.185 VO 31 IS Suppl 4 A1 Gkorila, A A1 Smyth, S A1 Tupper, P A1 Mcculloch, A A1 Sadeghi, N A1 Le Thanh, V A1 Sattar, A A1 Spencer, S A1 Zarrindej, K A1 Abdalla, M A1 Addley, S A1 Rencher, J A1 Sharma, G A1 Kashif, A A1 Siddiki, S A1 Alazzam, M A1 Soleymani Majd, H YR 2021 UL http://ijgc.bmj.com/content/31/Suppl_4/A75.3.abstract AB Objectives UCS comprises <5% of uterine malignancies, accounting for >15% associated mortality. With no established guidelines, we present our experience to determine clinical characteristics, treatment modalities and histology outcomes of UCS.Methods We conducted a multicentre retrospective cohort study, including all surgically managed UCS cases between March 2010 and January 2020. Data was collected on patients’ demographics, medical history, pre-operative and final histology and FIGO staging, peri-operative and post-operative findings.Results 82 (9.7%) UCS cases were identified from a total of 847 surgically managed uterine cancers, with 51 diagnosed with UCS. 3 cases were down and 12 up-staged following surgery. 15 cases of MRI lymphadenopathy led to a PPV of 40%. Positive lymph nodes and omentum were identified in 15.8% and 11.3% of cases respectively, with half of lymph node metastases diagnosed following systematic dissection (the majority of which were LVSI positive). There were no operative complication themes.View this table:Abstract EPV115/#333 Table 1 Pre-operative characteristics and ivestigations of patients with UCSView this table:Abstract EPV115/#333 Table 2 Treatment modalities and outcomes of patients with UCSConclusions UCS presented with almost double the incidence rate previously described. The overall accuracy of pre-operative staging was 81%. Our analysis showed that 86% of cases were managed laparoscopically, with more favourable peri-operative and post-operative profiles. Despite the lack of management guidelines, we stress the importance of urgent surgical treatment for UCS, in the form of total hysterectomy, bilateral salpingo-oophorectomy, systematic bilateral pelvic lymph node dissection and omentectomy. Data on adjuvant treatment, recurrence and survival is currently under analysis.